OpenVSafe by OpenVAERS
Search V-safe

SJ3-19935-21154

2 vaccinations 2 coded responses 4 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
606 / IL
Registered
2021-02-23
Relationship
Self
Race
Multiracial
Ethnicity
N/A

Timeline

  1. 2021-02-04
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-22
    Dose 2 — Pfizer-BioNTech
  3. 2021-02-23
    Registered in v-safe
  4. 2021-02-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Eye pain, Muscle spasms, Respiratory tract congestion — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: eye pain, muscle cramping, congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-02-23
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-02-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hyperhidrosis — Feeling: Good · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Sweating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-02-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-04Pfizer-BioNTech
22021-02-22Pfizer-BioNTech

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-23

Systemic reaction (other): eye pain, muscle cramping, congestion

2021-02-24

Systemic reaction (other): Sweating

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROEye pain ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROMuscle spasms ✓ ✓ ✓
SRORespiratory tract congestion ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release